These products are made by compounding pharmacies, which are not regulated by the FDA for safety, quality, or efficacy
By purchasing, you certify they will be used solely for research and not for human or animal consumption
50 & Target Kd: 65 pM (HGF) [1] In Vitro Dihexa binds with high affinity to HGF and both dihexa and its parent compound Norleucine 1-AngIV induce c-Met phosphorylation in the presence of subthreshold concentrations of HGF and augment HGF-dependent cell scattering
Subcutaneous injections can be less painful and easier to do yourself
Short-term room temperature exposure (around 1 month) during shipping/handling is generally acceptable if kept sealed, dry, and protected from heat/light
These injections are typically administered subcutaneously, with a recommended dosage of 250 g per cat on a weekly basis until anemia resolves and red blood cell values stabilize